Milestone Scientific appoints Peter Milligan as part-time CFO effective Feb 1, 2023

MILESTONE SCIENTIFIC INC.

Annual salary of $120,000 plus incentive bonus target of 40% of cash compensation payable in shares.
Eligible for $100,000 in annual restricted stock ($50k Feb 1, $50k Aug 1) valued at closing price, issued 60 days post-termination.
Milligan previously CFO at Melinta Therapeutics (led through Chapter 11), Exelis, and senior finance roles at ITT and AT&T.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Peter Milligan

Chief Financial Officer

MLSS · MILESTONE SCIENTIFIC INC.

Effective: 2023-02-01
Filed: February 6, 2023, 6:59 PM ET

On February 6, 2023, Milestone Scientific Inc. (the “Company”) announced the appointment of Peter Milligan as the Company’s Chief Financial Officer, on a part-time basis, effective February1, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Peter Milligan was appointed as Chief Financial Officer at MILESTONE SCIENTIFIC INC..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On February 6, 2023, Milestone Scientific Inc. (the “Company”) announced the appointment of Peter Milligan as the Company’s Chief Financial Officer, on a part-time basis, effective February1, 2023.

View on SEC.gov

MILESTONE SCIENTIFIC INC. filing history →

Source: SEC EDGAR

accession 0001437749-23-002584

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.